Quanex Building Products Corporation (NYSE:NX) (“Quanex” or the “Company”) today announced its results for the three months ended July 31, 2022.

The Company reported the following selected financial results:

  Three Months Ended July 31,   Nine Months Ended July, 31
($ in millions, except per share data) 2022   2021   2022   2021
Net Sales $324.0   $279.9   $914.0   $780.4
Gross Margin $72.6   $60.0   $201.0   $175.7
Gross Margin % 22.4%   21.4%   22.0%   22.5%
Net Income $25.9   $13.6   $63.7   $36.0
Diluted EPS $0.78   $0.41   $1.91   $1.08
               
Adjusted Net Income $26.2   $14.2   $64.0   $37.8
Adjusted Diluted EPS $0.79   $0.42   $1.92   $1.13
Adjusted EBITDA $44.2   $32.9   $113.8   $89.5
Adjusted EBITDA Margin % 13.6%   11.8%   12.5%   11.5%
               
Cash Provided by Operating Activities $51.7   $18.5   $49.9   $47.4
Free Cash Flow $46.0   $12.3   $30.4   $31.4

(See Non-GAAP Terminology Definitions and Disclaimers section, Non-GAAP Financial Measure Disclosure table, Selected Segment Data table and Free Cash Flow Reconciliation table for additional information)

George Wilson, President and Chief Executive Officer, stated, “We are proud of the results we posted for the third quarter, especially considering the ongoing inflationary challenges and macro-related uncertainties. Demand for our products held up nicely for most of the third quarter and results reflected the benefit from our pass-through pricing strategy; however, we did start to experience some softness in demand in Europe towards the end of July.

“Free Cash Flow increased significantly during the third quarter of this year compared to the same period last year. The improvement in Free Cash Flow was driven by a meaningful increase in net income. We were able to repay $25 million of bank debt and repurchase $5 million of our common stock during the quarter. Overall, our balance sheet and liquidity remain strong. We will continue to focus on generating cash, maintaining a healthy balance sheet, opportunistically repurchasing our stock and evaluating growth opportunities.” (See Non-GAAP Terminology Definitions and Disclaimers section and the reconciliation of Free Cash Flow to cash provided by operating activities for additional information)

Third Quarter 2022 Results Summary

Quanex reported net sales of $324.0 million during the three months ended July 31, 2022, which represents growth of 15.8% compared to $279.9 million for the same period of 2021. The increase was mostly attributable to higher prices related to the pass through of raw material cost inflation. More specifically, the Company realized net sales growth of 25.0% in its North American Fenestration segment, 17.0% in its North American Cabinet Components segment and 8.7% in its European Fenestration segment, excluding the foreign exchange impact. (See Sales Analysis table for additional information)

The increase in earnings for the three months ended July 31, 2022 was largely due to increased pricing and surcharges related to the pass through of raw material cost inflation and higher volumes in the North American Fenestration segment.

Balance Sheet & Liquidity Update

As of July 31, 2022, Quanex had total debt of $38.0 million and its leverage ratio of Net Debt to LTM Adjusted EBITDA improved to 0.1x.   (See Non-GAAP Terminology Definitions and Disclaimers section for additional information)

The Company’s liquidity increased to $332.0 million as of July 31, 2022, consisting of $50.0 million in cash on hand plus availability under its new Amended and Restated Senior Secured Revolving Credit Facility due 2027, less letters of credit outstanding.

Share Repurchases

Quanex’s Board authorized a $75 million share repurchase program in December of 2021. Repurchases under this program will be made in open market transactions or privately negotiated transactions, subject to market conditions, applicable legal requirements, and other relevant factors. The Company repurchased 216,000 shares of common stock for approximately $5.0 million at an average price of $23.29 per share during the three months ended July 31, 2022. As of July 31, 2022, approximately $68.4 million remained under the existing share repurchase authorization.

Outlook

Mr. Wilson commented, “We are reaffirming guidance for fiscal 2022, which is based on our strong results year-to-date coupled with ongoing conversations with our customers. Overall, demand for our products is still relatively healthy, but in addition to the softness in Europe we are starting to see signs of softness in North America, mainly in our cabinet components business. For the fourth quarter of this year, we now expect ~15% revenue growth in our North American Fenestration segment and low-single digit revenue growth in our North American Cabinet Components segment. Due to continued softness in Europe and the foreign exchange impact, we expect revenue to decline by ~15% in our European Fenestration segment in the fourth quarter. As a reminder, on a consolidated basis, we guided to net sales of $1.18 billion to $1.2 billion, which we expect will generate approximately $150 million to $155 million in Adjusted EBITDA* in fiscal 2022.

Longer-term, the underlying fundamentals remain positive for the residential housing industry in North America and in the markets we serve in Europe. Our balance sheet is strong and we are well-positioned to weather any storm, and we are also prepared to execute on our plan and create further value for shareholders over time.”

*When Quanex provides expectations for Adjusted EBITDA on a forward-looking basis, a reconciliation of the differences between the non-GAAP expectations and corresponding GAAP measures is generally not available without unreasonable effort. Certain items required for such a reconciliation are outside of the Company’s control and/or cannot be reasonably predicted or estimated, such as the provision for income taxes.

Conference Call and Webcast Information

The Company has also scheduled a conference call for Friday, September 2, 2022 at 11:00 a.m. ET (10:00 a.m. CT) to discuss the release. A link to the live audio webcast will be available on Quanex’s website at http://www.quanex.com in the Investors section under Presentations & Events.

Participants can pre-register for the conference call using the following link: https://register.vevent.com/register/BIe64ac12abde44f549078e7b4a916e837

Registered participants will receive an email containing conference call details for dial-in options. To avoid delays, it is recommended that participants dial into the conference call ten minutes ahead of the scheduled start time. A replay will be available for a limited time on the Company’s website at http://www.quanex.com in the Investors section under Presentations & Events.

About Quanex

Quanex Building Products Corporation is an industry-leading manufacturer of components sold to Original Equipment Manufacturers (OEMs) in the building products industry.  Quanex designs and produces energy-efficient fenestration products in addition to kitchen and bath cabinet components.   For more information contact Scott Zuehlke, Senior Vice President, Chief Financial Officer & Treasurer, at 713-877-5327 or scott.zuehlke@quanex.com.

Non-GAAP Terminology Definitions and Disclaimers

Adjusted Net Income (defined as net income further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges, asset impairment charges, other net adjustments related to foreign currency transaction gain/loss and effective tax rates reflecting impacts of adjustments on a with and without basis) and Adjusted EPS are non-GAAP financial measures that Quanex believes provide a consistent basis for comparison between periods and more accurately reflects operational performance, as they are not influenced by certain income or expense items not affecting ongoing operations. EBITDA (defined as net income or loss before interest, taxes, depreciation and amortization and other, net) and Adjusted EBITDA (defined as EBITDA further adjusted to exclude purchase price accounting inventory step-ups, transaction costs, certain severance charges, gain/loss on the sale of certain fixed assets, restructuring charges and asset impairment charges) are non-GAAP financial measures that the Company uses to measure operational performance and assist with financial decision-making.  Net Debt is defined as total debt (outstanding balance on the revolving credit facility plus financial lease obligations) less cash and cash equivalents. The leverage ratio of Net Debt to LTM Adjusted EBITDA is a financial measure that the Company believes is useful to investors and financial analysts in evaluating Quanex’s leverage. In addition, with certain limited adjustments, this leverage ratio is the basis for a key covenant in the Company’s credit agreement. Free Cash Flow is a non-GAAP measure calculated using cash provided by operating activities less capital expenditures. Quanex uses the Free Cash Flow metric to measure operational and cash management performance and assist with financial decision-making.   Free Cash Flow is measured before application of certain contractual commitments (including capital lease obligations), and accordingly is not a true measure of the Company’s residual cash flow available for discretionary expenditures. Quanex believes Free Cash Flow is useful to investors in understanding and evaluating the Company’s financial and cash management performance. Quanex believes that the presented non-GAAP measures provide a consistent basis for comparison between periods and will assist investors in understanding the Company’s financial performance when comparing results to other investment opportunities.  The presented non-GAAP measures may not be the same as those used by other companies. Quanex does not intend for this information to be considered in isolation or as a substitute for other measures prepared in accordance with U.S. GAAP.

Forward Looking Statements

Statements that use the words “estimated,” “expect,” “could,” “should,” “believe,” “will,” “might,” or similar words reflecting future expectations or beliefs are forward-looking statements. The forward-looking statements include, but are not limited to, the following: impacts from public health issues (including pandemics, such as the recent COVID-19 pandemic) on the economy and the demand for Quanex’s products, the Company’s future operating results, future financial condition, future uses of cash and other expenditures, expenses and tax rates, expectations relating to Quanex’s industry, and the Company’s future growth, including any guidance discussed in this press release. The statements and guidance set forth in this release are based on current expectations. Actual results or events may differ materially from this release. For a complete discussion of factors that may affect Quanex’s future performance, please refer to the Company’s Annual Report on Form 10-K for the fiscal year ended October 31, 2021, and the Company’s Quarterly Reports on Form 10-Q under the sections entitled “Cautionary Note Regarding Forward-Looking Statements” and “Risk Factors”. Any forward-looking statements in this press release are made as of the date hereof, and Quanex undertakes no obligation to update or revise any forward-looking statements to reflect new information or events.

                     
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(In thousands, except per share data)
(Unaudited)
                 
                 
    Three Months Ended July 31,   Nine Months Ended July, 31
    2022   2021   2022   2021
                 
Net sales   $ 324,037     $ 279,877     $ 913,970     $ 780,381  
Cost of sales     251,446       219,866       712,931       604,723  
Selling, general and administrative     28,822       27,766       87,774       88,299  
Restructuring charges     -       -       -       39  
Depreciation and amortization     9,734       10,683       30,554       32,543  
Operating income     34,035       21,562       82,711       54,777  
Interest expense     (724 )     (597 )     (1,849 )     (1,988 )
Other, net     398       188       905       645  
Income before income taxes     33,709       21,153       81,767       53,434  
Income tax expense     (7,801 )     (7,474 )     (18,098 )     (17,352 )
Net income   $ 25,908     $ 13,679     $ 63,669     $ 36,082  
                 
Earnings per common share, basic   $ 0.79     $ 0.41     $ 1.92     $ 1.09  
Earnings per common share, diluted   $ 0.78     $ 0.41     $ 1.91     $ 1.08  
                 
Weighted average common shares outstanding:                
Basic     32,999       33,359       33,093       33,194  
Diluted     33,173       33,650       33,256       33,518  
                 
Cash dividends per share   $ 0.08     $ 0.08     $ 0.24     $ 0.24  
                 

 
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands)
(Unaudited)
         
    July 31, 2022   October 31, 2021
ASSETS        
Current assets:        
Cash and cash equivalents   $ 50,030     $ 40,061  
Accounts receivable, net     109,467       108,309  
Inventories, net     138,237       92,529  
Prepaid and other current assets     8,651       8,148  
Total current assets     306,385       249,047  
Property, plant and equipment, net     175,404       178,630  
Operating lease right-of-use assets     45,722       52,708  
Goodwill     141,249       149,205  
Intangible assets, net     69,670       82,410  
Other assets     5,177       5,323  
Total assets   $ 743,607     $ 717,323  
         
LIABILITIES AND STOCKHOLDERS' EQUITY        
Current liabilities:        
Accounts payable   $ 84,527     $ 86,765  
Accrued liabilities     51,453       56,156  
Income taxes payable     13,709       6,038  
Current maturities of long-term debt     1,070       846  
Current operating lease liabilities     7,972       8,196  
Total current liabilities     158,731       158,001  
Long-term debt     55,458       52,094  
Noncurrent operating lease liabilities     38,768       45,367  
Deferred pension and postretirement benefits     4,498       4,737  
Deferred income taxes     21,086       21,965  
Other liabilities     14,929       15,377  
Total liabilities     293,470       297,541  
Stockholders’ equity:        
Common stock     373       373  
Additional paid-in-capital     251,359       254,162  
Retained earnings     315,471       259,718  
Accumulated other comprehensive loss     (41,365 )     (21,770 )
Treasury stock at cost     (75,701 )     (72,701 )
Total stockholders’ equity     450,137       419,782  
Total liabilities and stockholders' equity   $ 743,607     $ 717,323  
         

 
QUANEX BUILDING PRODUCTS CORPORATION
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOW
(In thousands)
(Unaudited)
       
  Nine Months Ended July, 31
  2022   2021
Operating activities:      
Net income $ 63,669     $ 36,082  
Adjustments to reconcile net income to cash provided by operating activities:      
Depreciation and amortization   30,554       32,543  
Stock-based compensation   1,707       1,470  
Deferred income tax   505       5,429  
Other, net   2,647       5,485  
Changes in assets and liabilities:      
Increase in accounts receivable   (5,306 )     (8,277 )
Increase in inventory   (48,280 )     (32,113 )
Increase in other current assets   (824 )     (2,768 )
Increase in accounts payable   2,765       1,600  
(Decrease) increase in accrued liabilities   (4,721 )     12,521  
Increase (decrease) in income taxes payable   7,522       (5,158 )
Decrease in deferred pension and postretirement benefits   (239 )     (158 )
Increase in other long-term liabilities   32       962  
Other, net   (177 )     (183 )
Cash provided by operating activities   49,854       47,435  
Investing activities:      
Capital expenditures   (19,488 )     (16,006 )
Proceeds from disposition of capital assets   134       3,138  
Cash used for investing activities   (19,354 )     (12,868 )
Financing activities:      
Borrowings under credit facilities   70,500       -  
Repayments of credit facility borrowings   (70,500 )     (45,000 )
Debt issuance costs   (1,210 )     -  
Repayments of other long-term debt   (1,301 )     (502 )
Common stock dividends paid   (7,916 )     (8,017 )
Issuance of common stock   502       16,272  
Payroll tax paid to settle shares forfeited upon vesting of stock   (1,412 )     (492 )
Purchase of treasury stock   (6,600 )     (5,741 )
Cash used for financing activities   (17,937 )     (43,480 )
Effect of exchange rate changes on cash and cash equivalents   (2,594 )     955  
Increase (decrease) in cash and cash equivalents   9,969       (7,958 )
Cash and cash equivalents at beginning of period   40,061       51,621  
Cash and cash equivalents at end of period $ 50,030     $ 43,663  
       

 
QUANEX BUILDING PRODUCTS CORPORATION
FREE CASH FLOW AND NET DEBT RECONCILIATION
(In thousands)
(Unaudited)
 
The following table reconciles the Company's calculation of Free Cash Flow, a non-GAAP measure, to its most directly comparable GAAP measure. The Company defines Free Cash Flow as cash provided by (used for) operating activities less capital expenditures.
       
  Three Months Ended July 31,   Nine Months Ended July, 31
  2022   2021   2022   2021
Cash provided by operating activities 51,735     18,475     $49,854     $47,435  
Capital expenditures (5,703 )   (6,207 )   (19,488 )   (16,006 )
Free Cash Flow $46,032     $12,268     $30,366     $31,429  
                       
                       
The following table reconciles the Company's Net Debt which is defined as total debt principal of the Company plus finance lease obligations minus cash.
                       
  As of July 31,        
  2022   2021            
Revolving credit facility $38,000     $58,000              
Finance lease obligations 20,105     15,951              
Total debt(1) 58,105     73,951              
Less: Cash and cash equivalents 50,030     43,663              
Net Debt $8,075     $30,288              
                       
(1) Excludes outstanding letters of credit.                      
                       

                                                   
QUANEX BUILDING PRODUCTS CORPORATION
NON-GAAP FINANCIAL MEASURE DISCLOSURE
(In thousands, except per share data)
(Unaudited)
                                                   
                                                   
    Three Months Ended   Three Months Ended   Nine Months Ended   Nine Months Ended  
Reconciliation of Adjusted Net Income and Adjusted EPS   July 31, 2022   July 31, 2021   July 31, 2022   July 31, 2021  
    NetIncome   DilutedEPS   NetIncome   DilutedEPS   NetIncome   DilutedEPS   NetIncome   DilutedEPS  
Net income as reported   $ 25,908     $ 0.78     $ 13,679     $ 0.41     $ 63,669     $ 1.91     $ 36,082     $ 1.08    
Net income reconciling items from below   257     $ 0.01     512     $ 0.01     291     $ 0.01     1,686     $ 0.05    
Adjusted net income and adjusted EPS   $ 26,165     $ 0.79     $ 14,191     $ 0.42     $ 63,960     $ 1.92     $ 37,768     $ 1.13    
                                                   
Reconciliation of Adjusted EBITDA   Three Months EndedJuly 31, 2022   Three Months EndedJuly 31, 2021   Nine Months EndedJuly 31, 2022   Nine Months EndedJuly 31, 2021  
    Reconciliation         Reconciliation         Reconciliation         Reconciliation        
Net income as reported   $ 25,908           $ 13,679           $ 63,669           $ 36,082          
Income tax expense   7,801           7,474           18,098           17,352          
Other, net   (398 )         (188 )         (905 )         (645 )        
Interest expense   724           597           1,849           1,988          
Depreciation and amortization   9,734           10,683           30,554           32,543          
EBITDA   43,769           32,245           113,265           87,320          
EBITDA reconciling items from below   419           682           550           2,160          
Adjusted EBITDA   $ 44,188           $ 32,927           $ 113,815           $ 89,480          
                                                   
Reconciling Items   Three Months EndedJuly 31, 2022   Three Months EndedJuly 31, 2021   Nine Months EndedJuly 31, 2022   Nine Months EndedJuly 31, 2021  
    Income Statement   Reconciling Items   Income Statement   Reconciling Items   Income Statement   Reconciling Items   Income Statement   Reconciling Items  
Net sales   $ 324,037     $ -     $ 279,877     $ -     $ 913,970     $ -     $ 780,381     $ -    
Cost of sales   251,446     -     219,866     (307 ) (1) 712,931     -     604,723     (307 ) (1)
Selling, general and administrative   28,822     (419 ) (2) 27,766     (375 ) (2) 87,774     (550 ) (2) 88,299     (1,814 ) (2)
Restructuring charges   -     -     -     -     -     -     39     (39 ) (3)
EBITDA   43,769     419     32,245     682     113,265     550     87,320     2,160    
Depreciation and amortization   9,734     -     10,683     -     30,554     -     32,543     -    
Operating income   34,035     419     21,562     682     82,711     550     54,777     2,160    
Interest expense   (724 )   -     (597 )   -     (1,849 )   -     (1,988 )   -    
Other, net   398     (82 ) (4) 188     79   (4) 905     (164 ) (4) 645     161   (4)
Income before income taxes   33,709     337     21,153     761     81,767     386     53,434     2,321    
Income tax expense   (7,801 )   (80 ) (5) (7,474 )   (249 ) (5) (18,098 )   (95 ) (5) (17,352 )   (635 ) (5)
Net income   $ 25,908     $ 257     $ 13,679     $ 512     $ 63,669     $ 291     $ 36,082     $ 1,686    
                                                   
Diluted earnings per share   $ 0.78           $ 0.41           $ 1.91           $ 1.08          
                                                   
                                                   
(1) Loss on damage to a plant caused by flooding.
(2) Transaction and advisory fees, loss on the sale of a plant.
(3) Restructuring charges related to the closure of manufacturing plant facilities.
(4) Foreign currency transaction (gains) losses.
(5) Impact on a with and without basis.
                                   

                             
QUANEX BUILDING PRODUCTS CORPORATION
SELECTED SEGMENT DATA
(In thousands)
(Unaudited)
                     
This table provides gross margin, operating (loss) income, EBITDA, and Adjusted EBITDA by reportable segment. Non-operating expense and income tax expense are not allocated to the reportable segments.
    NA Fenestration   EU Fenestration   NA Cabinet Components   Unallocated Corp & Other   Total
Three months ended July 31, 2022                    
Net sales   $ 184,744     $ 67,613     $ 72,480     $ (800 )   $ 324,037  
Cost of sales     142,970       47,212       61,543       (279 )     251,446  
Gross Margin     41,774       20,401       10,937       (521 )     72,591  
Gross Margin %     22.6 %     30.2 %     15.1 %         22.4 %
Selling, general and administrative     14,644       8,256       5,335       587       28,822  
Depreciation and amortization     4,044       2,327       3,273       90       9,734  
Operating income (loss)     23,086       9,818       2,329       (1,198 )     34,035  
Depreciation and amortization     4,044       2,327       3,273       90       9,734  
EBITDA     27,130       12,145       5,602       (1,108 )     43,769  
Transaction and advisory fees     -       -       -       419       419  
Adjusted EBITDA   $ 27,130     $ 12,145     $ 5,602     $ (689 )   $ 44,188  
Adjusted EBITDA Margin %     14.7 %     18.0 %     7.7 %         13.6 %
                     
Three months ended July 31, 2021                    
Net sales   $ 147,818     $ 71,114     $ 61,936     $ (991 )   $ 279,877  
Cost of sales     116,517       49,479       54,334       (464 )     219,866  
Gross Margin     31,301       21,635       7,602       (527 )     60,011  
Gross Margin %     21.2 %     30.4 %     12.3 %         21.4 %
Selling, general and administrative     13,428       7,525       5,130       1,683       27,766  
Depreciation and amortization     4,571       2,646       3,390       76       10,683  
Operating income (loss)     13,302       11,464       (918 )     (2,286 )     21,562  
Depreciation and amortization     4,571       2,646       3,390       76       10,683  
EBITDA     17,873       14,110       2,472       (2,210 )     32,245  
Loss on the damage of a plant     -       307       -       -       307  
Loss on sale of plant     375       -       -       -       375  
Adjusted EBITDA   $ 18,248     $ 14,417     $ 2,472     $ (2,210 )   $ 32,927  
Adjusted EBITDA Margin %     12.3 %     20.3 %     4.0 %         11.8 %
                     
Nine months ended July 31, 2022                    
Net sales   $ 509,283     $ 199,954     $ 207,711     $ (2,978 )   $ 913,970  
Cost of sales     396,505       138,147       179,791       (1,512 )     712,931  
Gross Margin     112,778       61,807       27,920       (1,466 )     201,039  
Gross Margin %     22.1 %     30.9 %     13.4 %         22.0 %
Selling, general and administrative     43,099       24,160       15,823       4,692       87,774  
Depreciation and amortization     12,221       7,418       10,653       262       30,554  
Operating income (loss)     57,458       30,229       1,444       (6,420 )     82,711  
Depreciation and amortization     12,221       7,418       10,653       262       30,554  
EBITDA     69,679       37,647       12,097       (6,158 )     113,265  
Transaction and advisory fees     -       -       -       550       550  
Adjusted EBITDA   $ 69,679     $ 37,647     $ 12,097     $ (5,608 )   $ 113,815  
Adjusted EBITDA Margin %     13.7 %     18.8 %     5.8 %         12.5 %
                     
Nine months ended July 31, 2021                    
Net sales   $ 422,077     $ 181,862     $ 179,492     $ (3,050 )   $ 780,381  
Cost of sales     328,278       122,631       155,370       (1,556 )     604,723  
Gross Margin     93,799       59,231       24,122       (1,494 )     175,658  
Gross Margin %     22.2 %     32.6 %     13.4 %         22.5 %
Selling, general and administrative     38,944       21,559       15,372       12,424       88,299  
Restructuring charges     39       -       -       -       39  
Depreciation and amortization     14,528       7,771       9,965       279       32,543  
Operating income (loss)     40,288       29,901       (1,215 )     (14,197 )     54,777  
Depreciation and amortization     14,528       7,771       9,965       279       32,543  
EBITDA     54,816       37,672       8,750       (13,918 )     87,320  
Loss on the damage of a plant     -       307       -       -       307  
Loss on sale of plant     375       -       -       1,439       1,814  
Restructuring charges     39       -       -       -       39  
Adjusted EBITDA   $ 55,230     $ 37,979     $ 8,750     $ (12,479 )   $ 89,480  
Adjusted EBITDA Margin %     13.1 %     20.9 %     4.9 %         11.5 %
                     

 
QUANEX BUILDING PRODUCTS CORPORATION
SALES ANALYSIS
(In thousands)
(Unaudited)
                 
    Three Months Ended July 31,   Nine Months Ended July, 31
    2022   2021   2022   2021
                 
NA Fenestration:              
  United States - fenestration $ 162,215     $ 129,291     $ 447,425     $ 369,809  
  International - fenestration   10,722       9,581       30,952       25,756  
  United States - non-fenestration   8,324       5,853       22,117       17,543  
  International - non-fenestration   3,483       3,093       8,789       8,969  
    $ 184,744     $ 147,818     $ 509,283     $ 422,077  
EU Fenestration:(1)              
  International - fenestration $ 49,041     $ 54,883     $ 148,525     $ 147,072  
  International - non-fenestration   18,572       16,231       51,429       34,790  
    $ 67,613     $ 71,114     $ 199,954     $ 181,862  
NA Cabinet Components:              
  United States - fenestration $ 4,857     $ 3,240     $ 13,288     $ 9,711  
  United States - non-fenestration   66,758       57,418       191,908       168,308  
  International - non-fenestration   865       1,278       2,515       1,473  
    $ 72,480     $ 61,936     $ 207,711     $ 179,492  
Unallocated Corporate & Other:              
  Eliminations $ (800 )   $ (991 )   $ (2,978 )   $ (3,050 )
    $ (800 )   $ (991 )   $ (2,978 )   $ (3,050 )
                 
Net Sales $ 324,037     $ 279,877     $ 913,970     $ 780,381  
                 
(1) Reflects reduction of $8.9 million and $11.7 million in revenue associated with foreign currency exchange rate impacts for the three and nine months ended July 31, 2022, respectively.
                 

 

 

Quanex (NYSE:NX)
過去 株価チャート
から 6 2024 まで 7 2024 Quanexのチャートをもっと見るにはこちらをクリック
Quanex (NYSE:NX)
過去 株価チャート
から 7 2023 まで 7 2024 Quanexのチャートをもっと見るにはこちらをクリック